ACR Advocates Changes to Improve IPPS, OPPS
ACR submitted official comments to the Centers for Medicare and Medicaid Services in response to the agency’s RFI related to the FY 2026 Hospital Inpatient Prospective Payment System.
Read moreMain Content
More Than 200 FDA Cleared AI Medical Imaging Products Now Available
Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.
If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.
Related ACR News
ACR Provides Recommendations About Fed Health Tech Programs
The College’s feedback is in response to the government’s request for information regarding the health technology ecosystem.
Read moreACR Drives Results at June AMA House of Delegates Meeting
The ACR team engaged in policy discussions, helping to shape the future of healthcare and ensure the voice of radiology is heard loud and clear.
Read more